Kim SK - Search Results

1

Oral delivery of chemical conjugates of heparin and deoxycholic acid in aqueous formulation.

Kim SK, Vaishali B, Lee E, Lee S, Lee YK, Kumar TS, Moon HT, Byun Y. Kim SK, et al. Thromb Res. 2006;117(4):419-27. doi: 10.1016/j.thromres.2005.03.027. Thromb Res. 2006. PMID: 15913716

2

Preparation and characterization of self-assembled nanoparticles of heparin-deoxycholic acid conjugates.

Park K, Kim K, Kwon IC, Kim SK, Lee S, Lee DY, Byun Y. Park K, et al. Among authors: kim sk, kim k. Langmuir. 2004 Dec 21;20(26):11726-31. doi: 10.1021/la048646i. Langmuir. 2004. PMID: 15595804

3

Synthesis and biological properties of insulin-deoxycholic acid chemical conjugates.

Lee S, Kim K, Kumar TS, Lee J, Kim SK, Lee DY, Lee YK, Byun Y. Lee S, et al. Among authors: kim sk, kim k. Bioconjug Chem. 2005 May-Jun;16(3):615-20. doi: 10.1021/bc049871e. Bioconjug Chem. 2005. PMID: 15898729

4

Tricaprylin microemulsion for oral delivery of low molecular weight heparin conjugates.

Kim SK, Lee EH, Vaishali B, Lee S, Lee YK, Kim CY, Moon HT, Byun Y. Kim SK, et al. Among authors: kim cy. J Control Release. 2005 Jun 20;105(1-2):32-42. doi: 10.1016/j.jconrel.2005.03.018. J Control Release. 2005. PMID: 15925422

5

Evaluation of absorption of heparin-DOCA conjugates on the intestinal wall using a surface plasmon resonance.

Kim SK, Kim K, Lee S, Park K, Park JH, Kwon IC, Choi K, Kim CY, Byun Y. Kim SK, et al. Among authors: kim cy, kim k. J Pharm Biomed Anal. 2005 Oct 4;39(5):861-70. doi: 10.1016/j.jpba.2005.06.014. Epub 2005 Sep 6. J Pharm Biomed Anal. 2005. PMID: 16143485

6

Cationic analog of deoxycholate as an oral delivery carrier for ceftriaxone.

Lee S, Kim SK, Lee DY, Park K, Kumar TS, Chae SY, Byun Y. Lee S, et al. Among authors: kim sk. J Pharm Sci. 2005 Nov;94(11):2541-8. doi: 10.1002/jps.20478. J Pharm Sci. 2005. PMID: 16200559

7

Efficacy of orally active chemical conjugate of low molecular weight heparin and deoxycholic acid in rats, mice and monkeys.

Lee YK, Kim SK, Lee DY, Lee S, Kim CY, Shin HC, Moon HT, Byun Y. Lee YK, et al. Among authors: kim cy, kim sk. J Control Release. 2006 Apr 10;111(3):290-8. doi: 10.1016/j.jconrel.2005.12.011. Epub 2006 Feb 23. J Control Release. 2006. PMID: 16497407

8

Pharmacokinetics of a new, orally available ceftriaxone formulation in physical complexation with a cationic analogue of bile acid in rats.

Lee S, Kim SK, Lee DY, Chae SY, Byun Y. Lee S, et al. Among authors: kim sk. Antimicrob Agents Chemother. 2006 May;50(5):1869-71. doi: 10.1128/AAC.50.5.1869-1871.2006. Antimicrob Agents Chemother. 2006. PMID: 16641464 Free PMC article.

9

Prevention effect of orally active heparin derivative on deep vein thrombosis.

Kim SK, Lee DY, Kim CY, Moon HT, Byun Y. Kim SK, et al. Among authors: kim cy. Thromb Haemost. 2006 Aug;96(2):149-53. Thromb Haemost. 2006. PMID: 16894457

10

Suppression of angiogenesis and tumor growth by orally active deoxycholic acid-heparin conjugate.

Lee DY, Kim SK, Kim YS, Son DH, Nam JH, Kim IS, Park RW, Kim SY, Byun Y. Lee DY, et al. Among authors: kim sy, kim sk, kim ys, kim is. J Control Release. 2007 Apr 23;118(3):310-7. doi: 10.1016/j.jconrel.2006.12.031. Epub 2007 Jan 12. J Control Release. 2007. PMID: 17291620

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,223 results

Search Page

Filters